New Microarray technology to check bird 'flu

USA - A new technology, named glycan microarray, can identify pathogens in a few hours and give advance warning of the ability of a virus to infect humans.

This could prove vital in efforts to control the spread of bird ‘flu, say its inventors, who work on the Consortium for Functional Glycomics (CFG), a project of the National Institute of Health’s National Institute of General Medical Sciences. CFG members work at the Scripps Research Institute, in cooperation with Mount Sinai School of Medicine and the Armed Forces Institute of Pathology, have now offered this new technology free to virus researchers.

Generally, thousands of DNA samples can be deposited in microarrays. However, for many pathogens it is the carbohydrates on the surface of most human or bird cells that provide a binding site, and once bound, a virus can then penetrate the host cell, which causes infections. The CFG was established to ascertain what carbohydrates coat which cells, and to catalogue their vulnerability to infections from various pathogens. Thus, in their new microarray, the researchers spread glycans (carbohydrate) molecules across the whole array. ‘Our technology allows hundreds of different varieties to be put on a single glycan array,’ explained Jeremy Berg, Director of the National Institute of General Medical Sciences. ‘There’s a universe of carbohydrates on the surface of cells. Our technology was not developed specifically for influenza. It is a very broad research tool.’
However, if an influenza virus, for example, is introduced, the hemagglutinin (HA) - glycoprotein on its surface - binds to the surface carbohydrates of a host cell and, using a tagged antibody, the technology could recognize the particular carbohydrate, from human or bird cell, to which the hemagglutinin has bound.

01.05.2006

More on the subject:
Read all latest stories

Related articles

Photo

Video • Mini-bones from the lab

Toward a personalized approach of bone cancer research and therapy

Researchers generated human mini bones in the lab which mirror the composition and function of human bone - a step toward the development of future patient-tailored models of bone cancers and tumors.

Photo

News • Driving genes of AMR in focus

Tracking the global spread of antimicrobial resistance

An international research team has provided valuable new information about what drives the global spread of genes responsible for antimicrobial resistance (AMR) in bacteria.

Photo

News • High-sensitivity blood test

New cancer testing method to make regular monitoring affordable

Scientists from Singapore discovered a novel low-cost method of testing for cancers. The test sequences heated clinical samples to isolate cancer-specific signatures found in a patient’s blood.

Related products

Alsachim - Dosimmune immunosupressant Alsachim – kit (CE-IVD or RUO)

Clinical Chemistry

· Alsachim - Dosimmune immunosupressant Alsachim – kit (CE-IVD or RUO)

Alsachim, a Shimadzu Group Company
Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Clinical Chemistry

· Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Alsachim, a Shimadzu Group Company
Alsachim – Dosinaco anticoagulant reagent kit (RUO)

Clinical Chemistry

· Alsachim – Dosinaco anticoagulant reagent kit (RUO)

Alsachim, a Shimadzu Group Company
ASP Lab Automation – SortPro Sample sorter

Sample Processing

· ASP Lab Automation – SortPro Sample sorter

ASP Lab Automation AG
Beckman Coulter – Access 2 Immunoassay System

Immunoassays

· Beckman Coulter – Access 2 Immunoassay System

Beckman Coulter Diagnostics
Subscribe to Newsletter